SCHEMBL4336526

SCHEMBL4336526

CCOc1ccc(CC(OC(C)C)C(=O)O)cc1NC(=O)COc1ccc(C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.45
PPARD Q03181 2/20 0.45
PPARA Q07869 2/20 0.45
MAPT P10636 5/20 0.44
ALDH1A1 P00352 5/20 0.44
HPGD P15428 1/20 0.44
TSHR P16473 1/20 0.44
HSD17B10 Q99714 1/20 0.44
SMN1; SMN2 Q16637 4/20 0.43
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
LMNA P02545 3/20 0.42
HTT P42858 3/20 0.42
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4337069 0.91 PPARG (0.46) PPARGPPARDPPARAMAPTALDH1A1
SCHEMBL4333407 0.90 PPARA (0.47) PPARGPPARDPPARAALDH1A1HPGD
SCHEMBL4345878 0.89 PPARA (0.50) PPARGPPARDPPARAALDH1A1HPGD
SCHEMBL4328620 0.85 L3MBTL1 (0.48) PPARGPPARDPPARAMAPTALDH1A1
SCHEMBL4347175 0.83 MEN1 (0.50) MAPTALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL4329366 0.83 SMN1; SMN2 (0.53) PPARAMAPTHPGDTSHRSMN1; SMN2
SCHEMBL4329938 0.81 KMT2A (0.52) PPARGPPARDPPARAMAPTALDH1A1
SCHEMBL4336292 0.80 PPARA (0.58) PPARGPPARDPPARAMAPTALDH1A1
SCHEMBL4328787 0.80 SMN1; SMN2 (0.57) MAPTHPGDTSHRSMN1; SMN2RAB9A
SCHEMBL4327205 0.78 ATM (0.42) PPARGPPARDPPARAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 PPARG 379/4885PPARD 753/4885PPARA 339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.